Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma

Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma

Item
http://www.wikidata.org/entity/Q35052538
An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACTSevere dermatologic reactions with bendamustine: a case series.Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan.A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphomaA Canadian perspective on the safe administration of bendamustine and the prevention and management of adverse events.Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer.Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma.Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review.Bendamustine associated immune suppression and infections during therapy of hematological malignancies.The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.
P2860

Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma

Item
http://www.wikidata.org/entity/Q35052538
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@ast
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@en
type
label
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@ast
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@en
prefLabel
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@ast
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932
P356
P1433
P1476
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932